Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AACR 2025: Quintet of investigational oncological drugs puts Ascentage on positive ascent
Pharmaphorum
Tuesday, April 29, 2025 - 8:11am
tags:
AACR, Ascentage Pharma, oncology, cancer
AACR 2025: MaaT Pharma, the gut microbiome, and immuno-oncology News
Pharmaphorum
Tuesday, April 29, 2025 - 8:10am
tags:
AACR, MaaT Pharma, microbiome, MaaT034
Medtronic Files for FDA Submission for the Hugo Robotic System
Medical Devices and Diagnostics Industry
Monday, April 28, 2025 - 9:40am
tags:
Medtech, Medtronic, Hugo, robotic surgery, FDA
Pfizer’s sasanlimab and BCG combo therapy improves EFS in bladder cancer trial
Clinical Trials Arena
Monday, April 28, 2025 - 9:39am
tags:
Pfizer, clinical trials, sasanlimab, BGC, non-muscle invasive bladder cancer
Perioperative Keytruda Cuts Risk of Negative Events by Over 25% in Head and Neck Cancer
BioSpace
Monday, April 28, 2025 - 9:38am
tags:
AACR, Merck, Keytruda, head and neck cancer
Germany’s Merck KGaA in $3.9 billion deal to buy US biotech firm SpringWorks
Investing.com
Monday, April 28, 2025 - 9:37am
tags:
Merck KGaA, M&A, SpringWorks Therapeutics
US Tariffs Will Raise Drug Prices for Patients, Sandoz CEO Says
MSN/Reuters
Monday, April 28, 2025 - 9:35am
tags:
Sandoz, drug pricing, tariffs
ALX Oncology doubles down on lead CD47 inhibitor after asset fails 2 midstage cancer trials
Fierce Biotech
Monday, April 28, 2025 - 9:34am
tags:
ALX Oncology, clinical trials, CD47, evorpacept, squamous cell carcinoma of the head and neck
FDA’s job cuts paint mixed picture for drugmakers’ R&D plans
Pharma Voice
Monday, April 28, 2025 - 9:32am
tags:
FDA, layoffs, R&D
AbbVie makes its tariffs-driven investment play
Pharmaphorum
Monday, April 28, 2025 - 9:31am
tags:
AbbVie, tariffs, drug manufacturing
Edwards' Manufacturing Base Helps Buffer Tariff Impact
Medical Devices and Diagnostics Industry
Monday, April 28, 2025 - 9:31am
tags:
Edward Lifesciences, Medtech, earnings, TAVR, tariffs
US pharma tariffs would raise US drug costs by $51 billion annually, report finds
Yahoo/Reuters
Friday, April 25, 2025 - 11:39am
tags:
tariffs, Donald Trump, drug pricing, PhRMA
US court decision stops compounders from making knockoffs of Novo Nordisk's semaglutide
Fierce Pharma
Friday, April 25, 2025 - 11:32am
tags:
Novo Nordisk, legal, semaglutide, drug compounding
AbbVie hikes its outlook on the back of two powerhouse drugs
Investors Business Daily
Friday, April 25, 2025 - 11:23am
tags:
AbbVie, Skyrizi, Rinvoq, earnings
Big Pharma Is Investing Billions In AI— And The Value Is Finally Starting To Show
Forbes
Friday, April 25, 2025 - 11:21am
tags:
artificial intelligence
Caribou, in reversal, scraps autoimmune cell therapy and cuts staff
BioPharma Dive
Friday, April 25, 2025 - 11:19am
tags:
Caribou Biosciences, CRISPR, layoffs, lupus, cancer, cell therapy
FDA puts Vyne in a twist, slapping hold on psoriasis trial over testicular toxicity concerns
Fierce Biotech
Friday, April 25, 2025 - 11:17am
tags:
Vyne Therapeutics, FDA, psoriasis, clinical trials
Samsung Bioepis releases Q2 2025 Biosimilar Market report
Drug Store News
Friday, April 25, 2025 - 11:12am
tags:
Samsung Bioepis, biosimilars, Stelara
AstraZeneca enters $200m AI cancer pact with Tempus and Pathos
Yahoo Finance
Friday, April 25, 2025 - 10:49am
tags:
AstraZeneca, Tempus AI, Pathos AI
Medtronic seeks FDA nod for insulin pump, furthering Abbott collab
Medtech Dive
Friday, April 25, 2025 - 10:47am
tags:
Medtech, Medtronic, FDA, insulin pump, Abbott Labs, CGMs, diabetes

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.